CyTOF (mass cytometry)
CyTOF (mass cytometry) enables deep, single‑cell profiling of vaccine‑induced immune responses, capturing the full complexity of immunogenicity beyond conventional assays. By simultaneously measuring 40 or more markers on individual cells, CyTOF provides an unparalleled view of the immune landscape, allowing comprehensive characterization of both innate and adaptive immune compartments.
In vaccine studies, CyTOF is a powerful tool for the evaluation of cell‑mediated immunity. It enables detailed definition of antigen‑specific T cells, B‑cell subsets, and innate immune responders, resolving phenotypes, activation states, functional cytokine profiles, memory differentiation, and polyfunctional responses induced by immunization. This high‑resolution approach reveals immune features that are often undetectable with lower‑dimensional methods.
CyTOF also supports longitudinal immune monitoring, making it possible to track how immune populations evolve over time, across doses, or following booster vaccinations. This capability enables the identification of immune patterns and signatures associated with vaccine efficacy, durability of response, and reactogenicity, supporting both mechanistic understanding and translational decision‑making.
CyTOF complements rather than replaces flow cytometry, offering unmatched depth and resolution when immune complexity, mechanism, and precision matter most—particularly in immunogenicity‑driven vaccine, monoclonal antibody, and antiviral programs.
When integrated with serological and molecular data, CyTOF contributes to a truly multidimensional, mechanistic view of vaccine‑elicited immunity, strengthening the evaluation of immunogenicity and advancing data‑driven vaccine development.
CyTOF vs. Conventional Flow Cytometry
| Feature | CyTOF (Mass Cytometry) | Flow Cytometry |
| Number of parameters | 40+ markers per cell | Typically 10–20 markers |
| Signal overlap | Minimal (metal isotopes) | High (fluorescence spillover) |
| Panel complexity | Highly complex, stable panels | Limited by fluorophore compatibility |
| Depth of immune profiling | Comprehensive, high‑dimensional | Moderate |
| Rare cell population detection | Excellent | Limited |
| Best suited for | Mechanistic studies, immune signatures, CMI, MoA analysis | Routine phenotyping, higher‑throughput screening |
